As of 2024-12-15, the Relative Valuation of Kezar Life Sciences Inc (KZR) is (163.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.78 USD, the upside of Kezar Life Sciences Inc based on Relative Valuation is -2508.6%.
The range of the Relative Valuation is (150.95) - (140.00) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.0x - 31.3x | 26.2x |
| Forward P/E multiples | 19.0x - 19.4x | 19.2x |
| Fair Price | (150.95) - (140.00) | (163.30) |
| Upside | -2326.4% - -2164.9% | -2508.6% |
| Date | P/E |
| 2024-11-20 | -1.04 |
| 2024-11-19 | -1.02 |
| 2024-11-18 | -1.03 |
| 2024-11-15 | -1.04 |
| 2024-11-14 | -1.04 |
| 2024-11-13 | -1.05 |
| 2024-11-12 | -1.04 |
| 2024-11-11 | -1.03 |
| 2024-11-08 | -1.02 |
| 2024-11-07 | -1.03 |
| 2024-11-06 | -1.03 |
| 2024-11-05 | -1.01 |
| 2024-11-04 | -0.98 |
| 2024-11-01 | -1.00 |
| 2024-10-31 | -1.03 |
| 2024-10-30 | -1.14 |
| 2024-10-29 | -1.04 |
| 2024-10-28 | -1.07 |
| 2024-10-25 | -1.09 |
| 2024-10-24 | -1.11 |
| 2024-10-23 | -1.12 |
| 2024-10-22 | -1.08 |
| 2024-10-21 | -1.10 |
| 2024-10-18 | -1.14 |
| 2024-10-17 | -1.13 |
| 2024-10-16 | -1.24 |
| 2024-10-15 | -1.21 |
| 2024-10-14 | -1.21 |
| 2024-10-11 | -1.18 |
| 2024-10-10 | -1.19 |
| 2024-10-09 | -1.20 |
| 2024-10-08 | -1.03 |
| 2024-10-07 | -1.07 |
| 2024-10-04 | -1.11 |
| 2024-10-03 | -1.15 |
| 2024-10-02 | -1.15 |
| 2024-10-01 | -1.10 |
| 2024-09-30 | -1.07 |
| 2024-09-27 | -0.76 |
| 2024-09-26 | -0.73 |
| 2024-09-25 | -0.76 |
| 2024-09-24 | -0.77 |
| 2024-09-23 | -0.79 |
| 2024-09-20 | -0.79 |
| 2024-09-19 | -0.81 |
| 2024-09-18 | -0.80 |
| 2024-09-17 | -0.80 |
| 2024-09-16 | -0.80 |
| 2024-09-13 | -0.79 |
| 2024-09-12 | -0.79 |